Overview
Ashley Morales is an associate in our San Diego office. Her practice primarily focuses on intellectual property disputes, including patent, trademark, trade dress, breach of contract, and unfair competition matters. She has experience enforcing and defending her clients’ intellectual property rights in U.S. District Court and before the Trademark Trial and Appeals Board. She represents clients in a variety of technological areas and products, including consumer products and services, pharmaceuticals, and medical devices.
Ashley received her law degree from Columbia Law School, where she was Executive Editor for the Columbia Journal of Environmental Law. She received her bachelor’s degree in chemistry and political science from the University of Southern California.
Ashley joined the firm in 2015.
Education
- University of Southern California (USC) (B.A. Chemistry and Political Science, 2012), cum laude
- Columbia Law School (J.D., 2015)
Recognition
Awards & Honors
- Named a 2023 Rising Star in IP by Managing IP
News & Insights
Articles
Co-authored, Hatch-Waxman And Copying: An Exception To The Exception?, Law360 (November 2017)
Co-authored, Evidence Of Copying Is Irrelevant In Hatch-Waxman Cases, Law360 (September 2016)
Litigation Blog
- A Request for Sanctions Before the ITC Is Not Appealable to the Federal Circuit
- An Award of Attorneys’ Fees and Costs under 35 U.S.C. §285 Does Not Preclude Sanctions Pursuant to the Court’s Inherent Authority
- Federal Circuit Avoids Deciding Whether Statements to Foreign Patent Office Can Disavow U.S. Claim Scope
- Potential Claim Construction Error Is Harmless When Not Relied Upon by the Board
- Patent Term Adjustment Under 35 U.S.C. 154(b)(1)(C)(iii) Requires Reversal of Adverse Determination of Patentability
- Required Testing as Part of an Offer for Sale Does Not Preclude a Finding of a Commercial Sale for On-Sale Bar Defense
- Prosecution History Disclaimer and Estoppel Lead To Noninfringement
- Registration of a Multi-Color Mark Does Not Require Acquired Distinctiveness
- Single-Entity Requirement for Infringement Under § 271(a) Does Not Apply to § 271(g)
Biotechnology Blog
- Johnson & Johnson Study Shows Promise for the Treatment and Potential Cure of Multiple Myeloma
- Nobel Prize in Medicine Awarded to American Scientists for Discovery of microRNA
- Branded Manufacturers Decline to Remove Patents From the Orange Book After Receiving Letters From the FTC
- USPTO Issues Training Materials to Examiners for Searching FDA and NIH Resources
- The FDA Approves Two New Gene Therapies for the Treatment of Sickle Cell Disease
- Federal Circuit Revisits Standard for Enablement of Antibody Claims
- Federal Circuit Finds Patent for Dietary Supplements Invalid Under § 101 for Reciting Naturally Occurring Milk Components
